CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that data presented at Digestive Disease Week (DDW) 2022 show ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that its artificial intelligence platforms will be featured in ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Iterative Scopes, the MIT spinout developing AI-powered ...

At a fork in the road, Aditya Khosla, Ph.D., is taking the path less traveled: one that will take him away from PathAI, the company he helped start half a decade ago. Khosla, who has also served as ...

From a new chief medical officer to new FDA clearances, here are six Iterative Scopes updates Becker’s has reported on in 2022. 1. Iterative Scopes rebranded, changing its name to Iterative Health. 2.

The goal of the rebrand is to better reflect the company’s use of artificial intelligence to improve clinical research and decision making within gastroenterology, according to an Oct. 20 news release ...

After chipping in to its last two venture funding rounds, Johnson & Johnson is taking an even bigger chance on Iterative Scopes. The startup, which spun out of MIT in 2017, is developing artificial ...

Artificial intelligence is increasingly shaking up the health care field — and, as evidenced by a new MIT spinout called Iterative Scopes, major pharmaceutical players are beginning to notice.

Iterative Scopes Inc. picked up $30 million in series A financing to advance artificial intelligence (AI)-powered precision medicine for gastroenterology. The money will be used to further develop the ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Iterative Scopes, in association with Provation, for its computer-aided ...